Skip to main content
Top
Published in: Calcified Tissue International 5/2016

01-05-2016 | Original Research

The Implications of the Sequestosome 1 Mutation P392L in Patients with Paget’s Disease in a United States Cohort

Authors: Margaret Seton, Marc Hansen, Daniel H. Solomon

Published in: Calcified Tissue International | Issue 5/2016

Login to get access

Abstract

Paget’s disease of bone (PDB) is associated with a germline mutation in Sequestosome1/p62 (SQSTM1) found in ≤16 % of sporadic cases worldwide, and in 19–46 % of those studied with familial PDB. The P392L is the most prevalent mutation identified to date. This mutation by itself does not confer PDB or define the phenotype of PDB in a given person. Environmental determinants remain elusive, although increasing age of the individual, other gene polymorphisms in the context of SQSTM1 mutations, and measles virus have been implicated. Measles exposure has been unexamined in this context. The goal of this study is to compare the background history and phenotype of patients with PDB carrying the SQSTM1 P392L mutation to those patients without. Focusing on age, ancestry, P329L mutation, family history, measles exposure, distribution of PDB, and age of onset, we examined outcomes at 10 years. We postulated that aging may play a role in defining phenotype, and that this may become more visible in a well-characterized cohort. This is an observational study focused on a cohort of patients with PDB drawn from the New England Registry in whom environmental and family history has been catalogued, linked to radiographic data. Of the 217 persons who were enrolled in the Registry, 42 (19 %) responded to a letter inviting them to participate in testing for the presence of the measles antibody, and in genetic testing for the P392L mutation. The mean age of the cohort in 2001 was 70 years (range 55–79); 27 were men (64 %). The measles antibody was found in all cases tested. Nine patients had the P392L mutation (21 %), 2 with familial PDB. In these persons, early diagnosis of disease and spinal stenosis marked the male phenotype only. European ancestry was noted in the minority of those with P392L mutation. Most deaths recorded occurred in the ninth decade of life or later. Spinal stenosis emerges as a prominent phenotype in SQSTM1 P392L-positive men with aging. In these 42 patients with PDB from the New England Registry, most do not carry the SQSTM1 P392L mutation, and many do not have European ancestry. Exposure to measles was confirmed in the majority.
Literature
1.
go back to reference Siris E, Roodman GD (2003) Paget’s disease section X Chap. 82. In: Favus MJ (ed) Primer on the metabolic bone diseases. ASBMR, Washington, DC, pp 495–506 Siris E, Roodman GD (2003) Paget’s disease section X Chap. 82. In: Favus MJ (ed) Primer on the metabolic bone diseases. ASBMR, Washington, DC, pp 495–506
2.
go back to reference van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C (2002) Incidence and natural history of Paget’s disease of bone in England and Wales. J Bone Miner Res 17:465–471CrossRefPubMed van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C (2002) Incidence and natural history of Paget’s disease of bone in England and Wales. J Bone Miner Res 17:465–471CrossRefPubMed
3.
go back to reference Wermers RA, Tiegs RD, Atkinson EJ, Achenbach SJ, Melton LJ 3rd (2008) Morbidity and mortality associated with Paget’s disease of bone: a population-based study. J Bone Miner Res 23:819–825CrossRefPubMedPubMedCentral Wermers RA, Tiegs RD, Atkinson EJ, Achenbach SJ, Melton LJ 3rd (2008) Morbidity and mortality associated with Paget’s disease of bone: a population-based study. J Bone Miner Res 23:819–825CrossRefPubMedPubMedCentral
4.
5.
go back to reference Laurin N, Brown JP, Morissette J, Raymond V (2002) Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 70:1582–1588CrossRefPubMedPubMedCentral Laurin N, Brown JP, Morissette J, Raymond V (2002) Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 70:1582–1588CrossRefPubMedPubMedCentral
6.
go back to reference Lucas GJ, Hocking LJ, Daroszewska A et al (2005) Ubiquitin-associated domain mutations of SQSTM1 in Paget s disease of bone: evidence for a founder effect in patients of British descent. J Bone Miner Res 20:227–231CrossRefPubMed Lucas GJ, Hocking LJ, Daroszewska A et al (2005) Ubiquitin-associated domain mutations of SQSTM1 in Paget s disease of bone: evidence for a founder effect in patients of British descent. J Bone Miner Res 20:227–231CrossRefPubMed
7.
go back to reference Ralston SH, Afzal MA, Helfrich MH et al (2007) Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget s disease of bone. J Bone Miner Res 22:569–577CrossRefPubMed Ralston SH, Afzal MA, Helfrich MH et al (2007) Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget s disease of bone. J Bone Miner Res 22:569–577CrossRefPubMed
8.
go back to reference Kurihara N, Zhou H, Reddy SV et al (2006) Expression of measles virus nucleocapsid protein in osteoclasts induces Paget’s disease-like bone lesions in mice. J Bone Miner Res 21:446–455CrossRefPubMed Kurihara N, Zhou H, Reddy SV et al (2006) Expression of measles virus nucleocapsid protein in osteoclasts induces Paget’s disease-like bone lesions in mice. J Bone Miner Res 21:446–455CrossRefPubMed
9.
go back to reference Merchant A, Smielewska M, Patel N et al (2009) Somatic mutations in SQSTM1 detected in affected tissues from patients with sporadic Paget’s disease of bone. J Bone Miner Res 24:484–494CrossRefPubMedPubMedCentral Merchant A, Smielewska M, Patel N et al (2009) Somatic mutations in SQSTM1 detected in affected tissues from patients with sporadic Paget’s disease of bone. J Bone Miner Res 24:484–494CrossRefPubMedPubMedCentral
10.
go back to reference Seton M, Moses AM, Bode RK, Schwartz C (2011) Paget’s disease of bone: the skeletal distribution, complications and quality of life as perceived by patients. Bone 48:281–285CrossRefPubMed Seton M, Moses AM, Bode RK, Schwartz C (2011) Paget’s disease of bone: the skeletal distribution, complications and quality of life as perceived by patients. Bone 48:281–285CrossRefPubMed
12.
go back to reference Tu SM, Som A, Tu B, Logothetis CJ, Lee MH, Yeung SC (2012) Effect of Paget’s disease of bone (osteitis deformans) on the progression of prostate cancer bone metastasis. Br J Cancer 107(4):646–651CrossRefPubMedPubMedCentral Tu SM, Som A, Tu B, Logothetis CJ, Lee MH, Yeung SC (2012) Effect of Paget’s disease of bone (osteitis deformans) on the progression of prostate cancer bone metastasis. Br J Cancer 107(4):646–651CrossRefPubMedPubMedCentral
13.
go back to reference Detheridge FM, Guyer PB, Barker DJ (1982) European distribution of Paget’s disease of bone. Br Med J (Clin Res Ed) 285:1005–1008CrossRef Detheridge FM, Guyer PB, Barker DJ (1982) European distribution of Paget’s disease of bone. Br Med J (Clin Res Ed) 285:1005–1008CrossRef
14.
go back to reference Falchetti A, Di Stefano M, Marini F et al (2009) Genetic epidemiology of Paget’s disease of bone in italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget’s disease of bone. Calcif Tissue Int 84:20–37CrossRefPubMed Falchetti A, Di Stefano M, Marini F et al (2009) Genetic epidemiology of Paget’s disease of bone in italy: sequestosome1/p62 gene mutational test and haplotype analysis at 5q35 in a large representative series of sporadic and familial Italian cases of Paget’s disease of bone. Calcif Tissue Int 84:20–37CrossRefPubMed
15.
go back to reference Eekhoff EW, Karperien M, Houtsma D et al (2004) Familial Paget’s disease in The Netherlands: occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations. Arthritis Rheum 50:1650–1654CrossRefPubMed Eekhoff EW, Karperien M, Houtsma D et al (2004) Familial Paget’s disease in The Netherlands: occurrence, identification of new mutations in the sequestosome 1 gene, and their clinical associations. Arthritis Rheum 50:1650–1654CrossRefPubMed
16.
go back to reference Rhodes EC, Johnson-Pais TL, Singer FR et al (2008) Sequestosome 1 (SQSTM1) mutations in Paget’s disease of bone from the United States. Calcif Tissue Int 82:271–277CrossRefPubMed Rhodes EC, Johnson-Pais TL, Singer FR et al (2008) Sequestosome 1 (SQSTM1) mutations in Paget’s disease of bone from the United States. Calcif Tissue Int 82:271–277CrossRefPubMed
17.
go back to reference Langston AL, Campbell MK, Fraser WD et al (2010) Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget s disease of bone. J Bone Miner Res 25:20–31CrossRefPubMed Langston AL, Campbell MK, Fraser WD et al (2010) Randomized trial of intensive bisphosphonate treatment versus symptomatic management in Paget s disease of bone. J Bone Miner Res 25:20–31CrossRefPubMed
18.
go back to reference Morissette J, Laurin N, Brown JP (2006) Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget s disease of bone. J Bone Miner Res 21:P38–P44CrossRefPubMed Morissette J, Laurin N, Brown JP (2006) Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget s disease of bone. J Bone Miner Res 21:P38–P44CrossRefPubMed
19.
go back to reference Albagha OM, Visconti MR, Alonso N et al (2013) Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget’s disease. J Bone Miner Res 28(11):2338–2346CrossRefPubMed Albagha OM, Visconti MR, Alonso N et al (2013) Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget’s disease. J Bone Miner Res 28(11):2338–2346CrossRefPubMed
20.
go back to reference Altman RD, Bloch DA, Hochberg MC, Murphy WA (2000) Prevalence of pelvic Paget’s disease of bone in the United States. J Bone Miner Res 15:461–465CrossRefPubMed Altman RD, Bloch DA, Hochberg MC, Murphy WA (2000) Prevalence of pelvic Paget’s disease of bone in the United States. J Bone Miner Res 15:461–465CrossRefPubMed
21.
go back to reference Rendina D, Gennari L, De Filippo G et al (2006) Evidence for increased clinical severity of familial and sporadic Paget’s disease of bone in Campania, southern Italy. J Bone Miner Res 21:1828–1835CrossRefPubMed Rendina D, Gennari L, De Filippo G et al (2006) Evidence for increased clinical severity of familial and sporadic Paget’s disease of bone in Campania, southern Italy. J Bone Miner Res 21:1828–1835CrossRefPubMed
22.
go back to reference Cundy HR, Gamble G, Wattie D, Rutland M, Cundy T (2004) Paget’s disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int 75:358–364CrossRefPubMed Cundy HR, Gamble G, Wattie D, Rutland M, Cundy T (2004) Paget’s disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int 75:358–364CrossRefPubMed
23.
go back to reference Mays S (2010) Archaeological skeletons support a northwest European origin for Paget’s disease of bone. J Bone Miner Res 25:1839–1841CrossRefPubMed Mays S (2010) Archaeological skeletons support a northwest European origin for Paget’s disease of bone. J Bone Miner Res 25:1839–1841CrossRefPubMed
Metadata
Title
The Implications of the Sequestosome 1 Mutation P392L in Patients with Paget’s Disease in a United States Cohort
Authors
Margaret Seton
Marc Hansen
Daniel H. Solomon
Publication date
01-05-2016
Publisher
Springer US
Published in
Calcified Tissue International / Issue 5/2016
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-015-0103-5

Other articles of this Issue 5/2016

Calcified Tissue International 5/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.